294 related articles for article (PubMed ID: 12487627)
1. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
[TBL] [Abstract][Full Text] [Related]
2. Atromentin and leucomelone, the first inhibitors specific to enoyl-ACP reductase (FabK) of Streptococcus pneumoniae.
Zheng CJ; Sohn MJ; Kim WG
J Antibiot (Tokyo); 2006 Dec; 59(12):808-12. PubMed ID: 17323650
[TBL] [Abstract][Full Text] [Related]
3. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
4. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.
Saito J; Yamada M; Watanabe T; Iida M; Kitagawa H; Takahata S; Ozawa T; Takeuchi Y; Ohsawa F
Protein Sci; 2008 Apr; 17(4):691-9. PubMed ID: 18305197
[TBL] [Abstract][Full Text] [Related]
6. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
8. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
[TBL] [Abstract][Full Text] [Related]
9. Unsaturated fatty acid synthesis in Enterococcus faecalis requires a specific enoyl-ACP reductase.
Dong H; Cronan JE
Mol Microbiol; 2022 Nov; 118(5):541-551. PubMed ID: 36100979
[TBL] [Abstract][Full Text] [Related]
10. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ; Su N; Murphy CK; Rock CO
J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
[TBL] [Abstract][Full Text] [Related]
11. The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance.
Zhu L; Bi H; Ma J; Hu Z; Zhang W; Cronan JE; Wang H
mBio; 2013 Oct; 4(5):e00613-13. PubMed ID: 24085780
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.
Saito J; Yamada M; Watanabe T; Kitagawa H; Takeuchi Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):576-8. PubMed ID: 16754986
[TBL] [Abstract][Full Text] [Related]
13. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
[TBL] [Abstract][Full Text] [Related]
14. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
[TBL] [Abstract][Full Text] [Related]
15. AG205, a novel agent directed against FabK of Streptococcus pneumoniae.
Takahata S; Iida M; Osaki Y; Saito J; Kitagawa H; Ozawa T; Yoshida T; Hoshiko S
Antimicrob Agents Chemother; 2006 Aug; 50(8):2869-71. PubMed ID: 16870790
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).
Hevener KE; Santarsiero BD; Lee H; Jones JA; Boci T; Johnson ME; Mehboob S
Acta Crystallogr F Struct Biol Commun; 2018 Feb; 74(Pt 2):105-112. PubMed ID: 29400320
[TBL] [Abstract][Full Text] [Related]
17. Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically cryptic.
Bi H; Zhu L; Wang H; Cronan JE
J Bacteriol; 2014 Jan; 196(1):170-9. PubMed ID: 24163335
[TBL] [Abstract][Full Text] [Related]
18. The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes.
Kater MM; Koningstein GM; Nijkamp HJ; Stuitje AR
Plant Mol Biol; 1994 Aug; 25(5):771-90. PubMed ID: 8075395
[TBL] [Abstract][Full Text] [Related]
19. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
[TBL] [Abstract][Full Text] [Related]
20. Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
Bergler H; Wallner P; Ebeling A; Leitinger B; Fuchsbichler S; Aschauer H; Kollenz G; Högenauer G; Turnowsky F
J Biol Chem; 1994 Feb; 269(8):5493-6. PubMed ID: 8119879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]